RUNX2 and cancer: This study revealed a previously unrecognized link between Runx2 and DTX3L in SMF and demonstrated that l‐carnitine exerted a significant therapeutic impact on cancer cachexia‐associated SMF, potentially through the upregulation of DTX3L.